Role of visceral surgery in oligometastases of non-gastrointestinal tumors

Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
R WahbaC Bruns

Abstract

Patients with oligometastatic disease can benefit from local treatment of the metastases. Under these premises the resection of liver metastases and visceral metastases of non-gastrointestinal tumors is performed increasingly more frequently in selected patients. The aim of this study was to evaluate the role of visceral oncological surgery in hepatic oligometastatic disease of non-gastrointestinal tumors according to the currently available literature. A systematic search of MEDLINE and PubMed was carried out focusing on the topics of oligometastases, liver resection and metastectomy for breast cancer, renal cell carcinoma, malignant melanoma, ovarian cancer and non-small cell lung cancer. The evidence is limited to retrospective studies and case series. In selected patients after liver resection and multimodal therapy 5‑year survival rates of 53% (breast cancer), 62% (renal cell carcinoma), 22% (malignant melanoma) and 50% (ovarian cancer) are described. For lung cancer (NSCLC) median survival was 12 month. Prognostic factors n were a disease free survival of >12 months, R0-resection, response to systemic therapy and extra hepatic/extra abdominal metastases. These could be selection criteria for liver resection. Recurrence li...Continue Reading

References

Nov 24, 2006·Annals of Surgery·René AdamDenis Castaing
Mar 14, 2007·World Journal of Surgery·Armin ThelenP Neuhaus
Mar 31, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P MarianiR J Salmon
Dec 7, 2010·Archives of Gynecology and Obstetrics·Hyun-Jin RohJoo-Hyun Nam
Mar 20, 2012·Journal of the American College of Surgeons·Ryan T GroeschlT Clark Gamblin
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoUNKNOWN ESMO Guidelines Working Group
Jun 19, 2013·The British Journal of Surgery·J-M AubinG Martel
Aug 26, 2014·Langenbeck's Archives of Surgery·Timothy L FitzgeraldEmmanuel E Zervos
Dec 3, 2014·The Lancet Oncology·Saeed DabestaniAxel Bex
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex
Jul 30, 2016·Current Opinion in Urology·Saeed DabestaniAxel Bex
Aug 4, 2016·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Georgios A MargonisTimothy M Pawlik
Feb 15, 2017·The Breast : Official Journal of the European Society of Mastology·Tae Gon YooAdam Bartlett
Jun 3, 2017·Breast Cancer Research and Treatment·Tae-Kyung YooByung Joo Song
Jun 8, 2017·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas K EigentlerClaus Garbe
Aug 31, 2017·The New England Journal of Medicine·Martin Reck, Klaus F Rabe
Jan 13, 2018·Journal of Oncology Practice·Sarah Jo StephensJoseph K Salama
Jan 18, 2018·The New England Journal of Medicine·Willemien J van DrielGabe S Sonke
Mar 8, 2018·International Journal of Clinical Oncology·Fumitaka IshigeYosuke Iwatate

❮ Previous
Next ❯

Citations

Jun 2, 2020·Expert Review of Anticancer Therapy·Maddalena DoniniMatteo Santoni
Jan 6, 2021·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·Astrid BauschkeUtz Settmacher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.